Your browser doesn't support javascript.
loading
Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistance.
Lee, Jeong Eun; Park, Hee Sun; Lee, Dahye; Yoo, Geon; Kim, Tackhoon; Jeon, Haeyon; Yeo, Min-Kyung; Lee, Choong-Sik; Moon, Jae Young; Jung, Sung Soo; Kim, Ju Ock; Kim, Sun Young; Park, Dong Il; Park, Yeon Hee; Lee, Jae Cheol; Oh, In-Jae; Lim, Dae Sik; Chung, Chaeuk.
Afiliação
  • Lee JE; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, South Korea.
  • Park HS; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, South Korea.
  • Lee D; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, South Korea.
  • Yoo G; Department of Biological Sciences, Seoul National University, Seoul 151-742, South Korea.
  • Kim T; National Creative Research Center for Cell Division and Differentiation, Department of Biological Sciences, Korea Advanced Institute of Science and Technology(KAIST), Daejeon 34141, South Korea.
  • Jeon H; National Creative Research Center for Cell Division and Differentiation, Department of Biological Sciences, Korea Advanced Institute of Science and Technology(KAIST), Daejeon 34141, South Korea.
  • Yeo MK; Department of Pathology, College of Medicine, Chungnam National University, Daejeon 35015, South Korea.
  • Lee CS; Department of Pathology, College of Medicine, Chungnam National University, Daejeon 35015, South Korea.
  • Moon JY; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, South Korea.
  • Jung SS; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, South Korea.
  • Kim JO; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, South Korea.
  • Kim SY; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, South Korea.
  • Park DI; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, South Korea.
  • Park YH; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, South Korea.
  • Lee JC; Department of Oncology, College of Medicine, University of Ulsan Asan Medical Center, Seoul 138-736, South Korea.
  • Oh IJ; Department of Internal Medicine, Chonnam National University Hwasun Hospital 322 Seoyangro, Hwasun-eup, Hwasun, Jeonnam, 519-809, South Korea.
  • Lim DS; Department of Biological Sciences, Seoul National University, Seoul 151-742, South Korea.
  • Chung C; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, South Korea. Electronic address: universe7903@gmail.com.
Biochem Biophys Res Commun ; 474(1): 154-160, 2016 05 20.
Article em En | MEDLINE | ID: mdl-27105908
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Adenocarcinoma / Proteínas Adaptadoras de Transdução de Sinal / Inibidores de Proteínas Quinases / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Coréia do Sul
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Adenocarcinoma / Proteínas Adaptadoras de Transdução de Sinal / Inibidores de Proteínas Quinases / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Coréia do Sul